Real-world outcomes and prognostic factors of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer: a multicenter study in Spain.

Martínez-Lago N, Reboredo López M, Riesco Martínez MC, López Peraita S, González Gómez B, Antonilli Pérez C, Ghanem I, Pérez Martelo M, López Alfonso A, Fernández Montes A, Agraso Busto S, Jiménez Gordo AM, Melian Sosa M, Gallardo Martín E, Cabezón-Gutiérrez L, Cousillas Castiñeiras A, LLanos Muñoz M, Ochoa Rivas MP, Gutiérrez Abad D, de la Cámara Gómez J, De Frutos González B, López Muñoz AM, Ferreiro Monteagudo R

Open source

DOI: 10.1016/j.esmogo.2026.100404
Published: 2026 Sep
Container: ESMO gastrointestinal oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.esmogo.2026.100404,
  title = {Real-world outcomes and prognostic factors of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer: a multicenter study in Spain.},
  author = {Martínez-Lago N and Reboredo López M and Riesco Martínez MC and López Peraita S and González Gómez B and Antonilli Pérez C and Ghanem I and Pérez Martelo M and López Alfonso A and Fernández Montes A and Agraso Busto S and Jiménez Gordo AM and Melian Sosa M and Gallardo Martín E and Cabezón-Gutiérrez L and Cousillas Castiñeiras A and LLanos Muñoz M and Ochoa Rivas MP and Gutiérrez Abad D and de la Cámara Gómez J and De Frutos González B and López Muñoz AM and Ferreiro Monteagudo R},
  year = {2026},
  journal = {ESMO gastrointestinal oncology},
  doi = {10.1016/j.esmogo.2026.100404},
  url = {https://doi.org/10.1016/j.esmogo.2026.100404}
}

RIS

TY  - JOUR
TI  - Real-world outcomes and prognostic factors of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer: a multicenter study in Spain.
AU  - Martínez-Lago N
AU  - Reboredo López M
AU  - Riesco Martínez MC
AU  - López Peraita S
AU  - González Gómez B
AU  - Antonilli Pérez C
AU  - Ghanem I
AU  - Pérez Martelo M
AU  - López Alfonso A
AU  - Fernández Montes A
AU  - Agraso Busto S
AU  - Jiménez Gordo AM
AU  - Melian Sosa M
AU  - Gallardo Martín E
AU  - Cabezón-Gutiérrez L
AU  - Cousillas Castiñeiras A
AU  - LLanos Muñoz M
AU  - Ochoa Rivas MP
AU  - Gutiérrez Abad D
AU  - de la Cámara Gómez J
AU  - De Frutos González B
AU  - López Muñoz AM
AU  - Ferreiro Monteagudo R
PY  - 2026
JO  - ESMO gastrointestinal oncology
DO  - 10.1016/j.esmogo.2026.100404
UR  - https://doi.org/10.1016/j.esmogo.2026.100404
ER  -

APA

N, M., M, R. L., MC, R. M., S, L. P., B, G. G., C, A. P., I, G., M, P. M., A, L. A., A, F. M., S, A. B., AM, J. G., M, M. S., E, G. M., L, C., A, C. C., M, L. M., MP, O. R., D, G. A., J, D. L. C. G., B, D. F. G., AM, L. M., & R, F. M. (2026). Real-world outcomes and prognostic factors of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer: a multicenter study in Spain.. ESMO gastrointestinal oncology. https://doi.org/10.1016/j.esmogo.2026.100404

Source records

pubmed · retrieved 2026-09-26T11:17:20.066Z